Conrad Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Conrad Pharma
Largest movements
- Financial fixed assets -€600,000
down €600,000 (-12.9%), from €4.7m to €4.1m
- Cash +€81,140
up €81,140 (+77.5%), from €104,724 to €185,864
mainly Investment in fixed assets (net) (+€585,981) and Net result for the year (+€199,229)
- Receivables within one year -€57,391
down €57,391 (-38.8%), from €147,769 to €90,378
of which Other amounts receivable: -€47,302
- Short-term financial debts -€600,057
down €600,057 (-97.3%), from €616,908 to €16,851
- Debts after one year -€280,431
down €280,431 (-8.1%), from €3.4m to €3.2m
of which Financial debts: -€280,431
- Other debts +€163,914
up €163,914 (+272.9%), from €60,072 to €223,987
- Current portion of long-term debt +€78,224
up €78,224 (+38.7%), from €202,207 to €280,431
- Gross operating margin +€74,823
up €74,823 (+17.4%), from €429,970 to €504,793
- Financial charges +€38,331
up €38,331 (+47.6%), from €80,512 to €118,843
- Other operating charges -€36,944
down €36,944 (-73.7%), from €50,142 to €13,198
- Financial income -€21,620
down €21,620 (-19.7%), from €109,705 to €88,085
- Staff costs +€19,603
up €19,603 (+18.9%), from €103,449 to €123,052
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €5,654,391 | €5,008,666 | -€645,725 | -11.4% |
| Fixed assets | 21/28 | €5,226,159 | €4,565,423 | -€660,736 | -12.6% |
| Intangible fixed assets | 21 | €233,280 | €194,840 | -€38,440 | -16.5% |
| Tangible fixed assets | 22/27 | €331,679 | €309,383 | -€22,296 | -6.7% |
| Land and buildings | 22 | €280,827 | €265,578 | -€15,249 | -5.4% |
| Plant, machinery and equipment | 23 | €10,164 | €19,418 | +€9,254 | +91.0% |
| Furniture and vehicles | 24 | €7,124 | €1,317 | -€5,807 | -81.5% |
| Other tangible fixed assets | 26 | €33,564 | €23,070 | -€10,495 | -31.3% |
| Financial fixed assets | 28 | €4,661,200 | €4,061,200 | -€600,000 | -12.9% |
| Current assets | 29/58 | €428,232 | €443,244 | +€15,012 | +3.5% |
| Stocks and contracts in progress | 3 | €155,214 | €147,132 | -€8,083 | -5.2% |
| Stocks | 30/36 | €155,214 | €147,132 | -€8,083 | -5.2% |
| Amounts receivable within one year | 40/41 | €147,769 | €90,378 | -€57,391 | -38.8% |
| Trade receivables | 40 | €92,361 | €82,272 | -€10,089 | -10.9% |
| Other amounts receivable | 41 | €55,408 | €8,106 | -€47,302 | -85.4% |
| Cash at bank and in hand | 54/58 | €104,724 | €185,864 | +€81,140 | +77.5% |
| Deferred charges and accrued income | 490/1 | €20,525 | €19,870 | -€655 | -3.2% |
| Total equity and liabilities | 10/49 | €5,654,391 | €5,008,666 | -€645,725 | -11.4% |
| Equity | 10/15 | €1,183,920 | €1,133,149 | -€50,771 | -4.3% |
| Contributions | 10/11 | €100,000 | €100,000 | = | 0.0% |
| Reserves | 13 | €1,083,920 | €1,033,149 | -€50,771 | -4.7% |
| Distributable reserves | 133 | €1,083,920 | €1,033,149 | -€50,771 | -4.7% |
| Amounts payable | 17/49 | €4,470,471 | €3,875,517 | -€594,954 | -13.3% |
| Amounts payable after more than one year | 17 | €3,445,698 | €3,165,268 | -€280,431 | -8.1% |
| Financial debts | 170/4 | €3,195,698 | €2,915,268 | -€280,431 | -8.8% |
| Other amounts payable | 178/9 | €250,000 | €250,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €990,645 | €665,066 | -€325,579 | -32.9% |
| Current portion of amounts payable after more than one year | 42 | €202,207 | €280,431 | +€78,224 | +38.7% |
| Financial debts | 43 | €616,908 | €16,851 | -€600,057 | -97.3% |
| Credit institutions | 430/8 | €616,908 | €16,851 | -€600,057 | -97.3% |
| Trade debts | 44 | €61,371 | €64,249 | +€2,878 | +4.7% |
| Suppliers | 440/4 | €61,371 | €64,249 | +€2,878 | +4.7% |
| Taxes, remuneration and social security | 45 | €50,087 | €79,549 | +€29,462 | +58.8% |
| Taxes | 450/3 | €38,415 | €66,250 | +€27,836 | +72.5% |
| Remuneration and social security | 454/9 | €11,672 | €13,298 | +€1,626 | +13.9% |
| Other amounts payable | 47/48 | €60,072 | €223,987 | +€163,914 | +272.9% |
| Accrued charges and deferred income | 492/3 | €34,128 | €45,184 | +€11,056 | +32.4% |
| Remuneration, social security and pensions | 62 | €103,449 | €123,052 | +€19,603 | +18.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €72,673 | €74,756 | +€2,082 | +2.9% |
| Other operating charges | 640/8 | €50,142 | €13,198 | -€36,944 | -73.7% |
| Gross operating margin | 9900 | €429,970 | €504,793 | +€74,823 | +17.4% |
| Operating profit (loss) | 9901 | €203,706 | €293,788 | +€90,081 | +44.2% |
| Financial income | 75/76B | €109,705 | €88,085 | -€21,620 | -19.7% |
| Recurring financial income | 75 | €109,705 | €88,085 | -€21,620 | -19.7% |
| Financial charges | 65/66B | €80,512 | €118,843 | +€38,331 | +47.6% |
| Recurring financial charges | 65 | €80,512 | €118,843 | +€38,331 | +47.6% |
| Profit (loss) for the period before taxes | 9903 | €232,899 | €263,029 | +€30,130 | +12.9% |
| Income taxes | 67/77 | €44,313 | €63,800 | +€19,487 | +44.0% |
| Profit (loss) for the period | 9904 | €188,587 | €199,229 | +€10,642 | +5.6% |
| Profit (loss) for the period to be appropriated | 9905 | €188,587 | €199,229 | +€10,642 | +5.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.